Document:

EXHIBIT
10.16

 

WELLTOWER INC.

Summary of Director Compensation

For each calendar year, each non-employee member of the
Board of Directors of Welltower Inc. (the “Company”) will receive an annual
retainer of $85,000, payable in equal quarterly installments. If there is a
non-employee director serving as the Chairman of the Board, such individual
will receive an additional retainer of $125,000. Additionally, the chairs of
the Audit Committee, the Compensation Committee and the Nominating/Corporate
Governance Committee will receive additional retainers of $25,000, $20,000 and
$15,000, respectively. If the Board of Directors holds more than four meetings
in a year, each non-employee member of the Board will receive $1,500 for each
meeting attended in excess of four meetings. With respect to the Audit,
Compensation, Executive and Nominating/Corporate Governance Committees, if any
of these committees holds more than four meetings in a year, each non-employee
member of these committees will receive $1,000 for each meeting attended in
excess of four meetings.  

Each of the non-employee directors will receive, in each
calendar year, a grant of deferred stock units with a value of $140,000,
pursuant to the Company’s 2016 Long-Term Incentive Plan. The deferred stock
units will be convertible into shares of common stock of the Company on the anniversary
of the date of the grant. Recipients of the deferred stock units also will be
entitled to dividend equivalent rights.Exhibit 10.1

 

 

Origo Acquisition Corporation

708 Third Avenue

New York, New York 10017

 

February 17, 2017

 

 

Aina Le’a, Inc.

Suite 2617, 69-201 Waikoloa Beach Drive

Waikoloa, Hawaii 96738

 

 

Ladies and Gentlemen:

 

Effective as of the date hereof, Origo
Acquisition Corporation (the “Company”) hereby terminates the Merger Agreement (the “Merger Agreement”),
dated December 19, 2016, by and among the Company, Aina Le’a, Inc. (“Aina Le’a”) and Aina Le’a Merger
Sub, Inc., a wholly-owned subsidiary of Aina Le’a (“Merger Sub”), pursuant to (1) Sections 8.1(e) of the Merger
Agreement because (i) Aina Le’a breached the covenant contained in Section 5.7 of the Merger Agreement and (2) pursuant to
Section 8.1(f) because there has been a Material Adverse Effect on the Company which is uncured and continuing. Capitalized terms
used but not defined herein shall have the meanings ascribed to such terms in the Merger Agreement.

 

In addition, effective as of the date
hereof, the Company hereby provides notice of additional breaches by Aina Le’a of the Merger Agreement based on information
available to the Company as of the date hereof, including, among others, breaches of the following provisions: Section 5.1(a) (by
failing to give the Company and its Representatives access to requested information about Aina Le’a and its operations, including
without limitation Aina Le’a’s ongoing financing activities), Section 5.8(iv) (failure to provide prompt notice of
the filing of a foreclosure action on a parcel of land material to the initial phase of Aina Le’a’s development project),
Section 5.8(v) (failure to provide prompt notice of the filing of a foreclosure action on a parcel of land material to the initial
phase of Aina Le’a’s development project), 5.9 and 5.11 (Aina Le’a’s failure to use commercially reasonable
efforts and to cooperate fully with the Company and its Representatives to prepare and file the Registration Statement). For purposes
these sections, please consider this a notice to cure with respect to these provision to the extent required by Section 8.1(e)
of the Merger Agreement. However, we reserve the right to take the position, and we hereby take the position that, these breaches
are not curable. Therefore, please consider this entire letter a notice of termination of the Merger Agreement effective immediately.

 

 

 

ORIGO ACQUISITION CORPORATION

 

 

 

By: /s/ Edward J. Fred

Name: Edward J. Fred

Title: Chief Executive Officer
and PresidentExhibit 10.2

 

 

Origo Acquisition Corporation

708 Third Avenue

New York, New York 10017

 

February 22, 2017

 

 

Aina Le’a, Inc.

Suite 2617, 69-201 Waikoloa Beach Drive

Waikoloa, Hawaii 96738

 

 

Ladies and Gentlemen:

 

We note Aina Le’a, Inc. (“Aina
Le’a”) yesterday filed with the Securities and Exchange Commission its Current Report on Form 10-Q for the quarter
ended December 31, 2016 (the “10-Q”). We further note that Aina Le’a included in Note 10 to the financial statements
(“Footnote 10”) for the quarter ended December 31, 2016 filed with the 10-Q an inaccurate statement concerning the
Termination Letter (the “Termination Letter”), dated February 17, 2017, sent by Origo Acquisition Corporation (the
“Company”) to Aina Le’a terminating, effective immediately, the Merger Agreement (the “Merger Agreement”),
dated December 19, 2016, by and among the Company, Aina Le’a and Aina Le’a Merger Sub, Inc., a wholly-owned subsidiary
of Aina Le’a (“Merger Sub”). The Company indicated that the Termination Letter was effective immediately pursuant
to (1) Sections 8.1(e) of the Merger Agreement because Aina Le’a breached the covenant contained in Section 5.7 of the Merger
Agreement and (2) pursuant to Section 8.1(f) because there has been a Material Adverse Effect on Aina Le’a which is uncured
and continuing. Capitalized terms used but not defined herein shall have the meanings ascribed to such terms in the Merger Agreement.

 

Based on information contained in the
Form 10-Q, the Company hereby supplements the Termination Letter and provides notice that the Company believes that information
contained in Footnote 10 further demonstrates there has been a Material Adverse Effect on Aina Le’a, which is uncured and
continuing. The Termination Letter, as supplemented by this letter, is a notice of termination of the Merger Agreement effective
as of the date of the Termination Letter.

 

 

 

 

ORIGO ACQUISITION CORPORATION

 

 

 

By: /s/ Edward J. Fred

Name: Edward J. Fred

Title: Chief Executive Officer
and PresidentEX-10.1

 Exhibit 10.1 

 
 

 
 10b5-1 Preset Diversification Program® (PDP)1 
 Table of Contents 

 

	Part I.	Account and Plan Information. Instructions: To be completed by MSSB and reviewed by the Seller. 

  

	Part II.	Trade Schedules. 

 Trade Schedule A – Notice and Authorization of
Exercise of Stock Options and Sale of Underlying Stock. Instructions: May not be applicable for some plans. For use by any seller who wishes to sell shares obtained upon the exercise of stock options. When applicable, to be completed by MSSB
and reviewed by the Seller. This Trade Schedule will be provided to the Issuer as Notice of the intention to exercise stock options. 

Trade Schedule B – Sale of Clean Stock/Control Stock/Restricted Stock Awards or Units or ESPP Stock. Instructions: May not be
applicable for some plans. For use by any seller who wishes to sell these types of shares. When applicable, to be completed by MSSB and reviewed by the Seller.  
  

	Part III.	Sales Plan Disclosures and Representations. Instructions: The Seller must review and understand these disclosures and representations. The Seller is required to sign the last page of this Part III.

  

	Part IV.	Exhibits. 

 Exhibit A – Issuer Representation Letter.
Instructions: To be reviewed and executed by an authorized representative of the Issuer. 
 Exhibit B – Seller
Representation Letter. Instructions: May not be applicable for some plans. To be reviewed and executed only by those sellers required to sell shares pursuant to Rule 144. 

Exhibit C – Section 16 Authorization Letter. Instructions: May not be applicable for some plans. To be reviewed
and signed only by those sellers who are required to comply with Section 16 of the Exchange Act. Not required if MSSB already has an Authorization Letter on file for the Seller. If required, this Authorization Letter will be provided to the
Issuer’s Section 16 Compliance Officer. 
  

							
	 	  	 	  	 Document
	  	To Be Signed By
				
	Part I	  		  	Account and Plan Information	  	N/A
				
	Part II	  	Trade Schedule A	  	Notice and Authorization of Exercise of Stock Options and Sale of Underlying Stock	  	N/A
				
	Part II	  	Trade Schedule B	  	Sale of Clean Stock/Control Stock/Restricted Stock Awards or Units or ESPP Stock	  	N/A
				
	Part III	  		  	Sales Plan Disclosures and Representations	  	Seller and MSSB
				
	Part IV	  	Exhibit A	  	Issuer Representation Letter	  	Issuer
				
	Part IV	  	Exhibit B	  	Seller Representation Letter	  	Seller,
 if applicable

				
	Part IV	  	Exhibit C	  	Section 16 Authorization Letter	  	Seller,
 if applicable

  
  

1 Preset Diversification Program is a registered Trademark of Morgan Stanley Smith Barney LLC, protected
in the United States and other countries. 

  
 Page 6 

 PART I 

Account and Plan Information 

Instructions: To be completed by MSSB and reviewed by the Seller. 

The undersigned (referred to hereinafter as the “Seller”, “I” or “me”) hereby appoints Morgan Stanley Smith
Barney LLC (“MSSB”) as my agent for the purposes of implementing this Sales Plan (this “Plan”) that complies with the requirements of Rule 10b5-1(c)(1) under the Securities Exchange Act of 1934, as amended (the
“Exchange Act”) as outlined below and for the purpose of executing this Plan. I understand that this Plan is subject to review prior to acceptance by MSSB and that, upon acceptance, MSSB will use commercially reasonable efforts to
perform its obligations under this Plan. 
 The appointment of MSSB is for the purpose of selling my securities pursuant to the terms and conditions set
forth below. Subject to such terms and conditions, MSSB accepts such appointment. This Plan is valid only for the specific security, account number and maximum total shares indicated: 

Issuer (the “Issuer”): Bristow Group
Inc.                Trading Symbol: BRS 
 Adoption
Date: February 20 , 2017                         Plan Type: New Plan 

The date on which the Seller executes this Plan will be defined as the Adoption Date (the “Adoption Date”). 

Seller’s Name: Caledonia Investments PLC 

Account #: XXX –
XXXXXX                                 FA Number: XXX 

Selling Start Date: March 6, 2017 

Note: The “Selling Start Date” may be no sooner than 14 days after the Adoption Date that this Plan is executed. 

Plan End Date: August 10,
2018                             Commission: $0.04 per share 

Seller’s Affiliation Status: ☒  144 affiliate    ☐  Section 16
insider    ☐  Non 144 Affiliate but subject to trading 
 windows    ☐  Other 

Share Type:    ☐  Options    ☒  Shares already
owned    ☐  Restricted Stock Award /Units    ☐  other 
 Plan Total Share
Quantity: Trade Schedule A:     N/A             

                          
                  Trade Schedule B:     1,835,000     

                          
                  Total Shares:             1,835,000     

 

			
	 For Internal Use
Only:    ☐  Drop-Ins    ☐  No-Sales Periods

M    S    P
  

Entered                    
Uploaded                     Sent to
Branch                    
  

Additional Notes:
	 	 Received                    
Entered                    
Checked                    
  

Additional Notes:

  
 Page 7 

 Notice: 
  

			
	 To the Seller:
  

Name: Caledonia Investments PLC
 Address: Stratton
House,5 Stratton Street
 London UK
 Telephone:
          
 Fax: 44 20 7802 8090

E-Mail: alan.murran@caledonia.com
	  	 Copies to:
 Name:   (1) Alan
Murran, Investment Director
 Telephone: +44 20 7802 8464

E-Mail: alan.murran@caledonia.com

              (2) Krista Burwood, Deputy Company Secretary

Telephone: +44 20 7802 8428
 E-Mail:
krista.burwood@caledonia.com
               (3)
contractnotes@caledonia.com
  
 Address: Stratton House, 5 Stratton Street, London
UK
  
 (After June 1, 2017: 30 Buckingham Gate, London,

UK SW1E 6NN)
 Fax: +44 20 7802
8090

  

			
	 To Issuer:
 Name: Chip Earle, Senior
VP and General Counsel
 Corporation Bristow Group Inc.

Address: 2103 City West Blvd, 4th Floor

Houston, TX 77042
  

Telephone: 713-267-7616
 Fax: 713-267-7695

E-Mail: chip.earle@bristowgroup.com
	  	 Copies to:
 Name: John Vogel

Corporation Crowell & Moring
 Address: 1001
Pennsylvania Avenue, N.W.
 Washington, DC
  

Telephone: 202-624-2764
 Fax: 202 628 5116

E-Mail: jvogel@crowell.com

  

			
	 To: MSSB 10b5-1 Preset Diversification Program Department
  

Primary Contact: Natalie Siriban-Lee
 Alternate Contact:
Rich Baker
 Address: 1 New York Plaza, 38th Floor

                New York, NY 10004

 
 Telephone: 646-536-0463 or 646-536-0477

Fax:            212-507-3942

E-mail:       pdpdesk@morganstanley.com
	  	 Copies to: MSSB Financial Advisor
  

Primary Contact: Keith Mackay
 Alternate Contact: Skip
Moosher
 Ops Manager: Quanta Sterling
 Address:
MS 1850 K Street NW Suite 900
 Washington, DC 20006
  

Telephone: 202-857-5431
 Fax: 202-318-8188

E-mail: keith.mackay@morganstanley.com

This Part I is an integral part of this Plan entered into by the Seller with MSSB and is subject to the terms and conditions set forth therein. 

  
 Page 8 

 PART II 

Trade Schedule A – Notice and Authorization of Exercise of Stock Options and Sale of Underlying Stock. 

Instructions: May not be applicable for some plans. For use by any seller who wishes to sell shares obtained upon the exercise of stock options. When
applicable, to be completed by MSSB and reviewed by the Seller. This Trade Schedule will be provided to the Issuer as Notice of the intention to exercise stock options. 

Name of Seller: Caledonia Investments PLC            Name of Issuer: Bristow Group
Inc. 
 I understand that it is my responsibility to ensure that my employee stock options (the “Options”) will be vested prior to the
purchase of shares (the “Shares”) of common stock of the Issuer upon exercising the options and will be vested prior to their associated sale periods listed below and will not expire before such sale periods. I also acknowledge
responsibility for notifying MSSB in the event of an expiration of the Options under the Issuer’s stock option plan that will prevent the occurrence of one or more transactions listed below. If I authorize the exercise of more than one vested
Option grant at the same limit price, the Options will be exercised in the order listed below. I further acknowledge that in the event Options cannot be exercised and the corresponding Shares cannot be sold for any reason, including the occurrence
of a suspension pursuant to this Plan, the term of this Plan will not be affected thereby and will end on the originally scheduled Plan End Date. I represent that the information below is accurate. 

MSSB MAY NOT ACCEPT A PLAN THAT COMMENCES SALES WITHIN 14 CALENDAR DAYS OF ADOPTION DATE. 

 

	 	1.	The following shall constitute my irrevocable direction and authorization to exercise the Options and sell the Shares as follows: 

*** INFORMATION ON GRID MUST BE TYPED *** 
  

																	
	 (a)

Date of Grant
	  	 (b)

Grant ID
	  	
(c)
Strike Price
	  	
(d)
Option Vest Date
	  	 (e)

Option

Expiration Date
	  	 (f)

Sale Period(s)
	  	 (g)

Number of Shares
to be Sold
	  	 (h)

Limit Price

	  	  	  	  	  	 Start Date
	  	 End Date
	  	  
									
		  		  		  		  		  		  		  		  	
									
	 N/A
	  	N/A	  	N/A	  	N/A	  	N/A	  	N/A	  	N/A	  	N/A	  	N/A
									
		  		  		  		  		  		  		  		  	
									
		  		  		  		  		  		  		  		  	
									
		  		  		  		  		  		  		  		  	

 Note: Insert additional rows as necessary. 
  

			
	 “No Sale” Periods (if
any)

	 Start Date
	 	 End Date

		 	
		 	

 The maximum number of Shares to be sold under this Trade Schedule A is N/A. 

 

	 	1.	I hereby irrevocably authorize the Issuer to deliver Shares through the Depository Trust Company (DTC) to 

  

	 	    	Morgan Stanley Smith Barney LLC – DTC#: 015 

  

	 	    	Deliver to Account #: XXX – XXXXXX 

  
 Page 9 

	 	2.	I hereby authorize MSSB or it affiliates, as applicable, to wire a cash amount sufficient to cover the cost of the exercise and any withholding taxes due to either the Issuer or, if applicable, the Issuer’s outside
stock option plan administrator upon the exercise of any Options exercised and underlying Shares sold pursuant to this Plan. 

Instructions for Trade Schedule A: 
  

	 	•	 	Please list all Options to be exercised and sold in the order of proposed exercise and sale. If a specific grant is not attributed to each individual Sale Period, Options will be exercised in the order that the grants
are listed above. 

  

	 	•	 	In columns (a) through (e) please provide the details of the Option grants to be exercised and sold. 

  

	 	•	 	In column (f), state the first and last date on which the Shares are authorized to be sold during the Sale Period (Share sales may occur on or between these dates). If, during any Sale Period the stated price is not
reached for some or all of these Shares, they will not be carried over into any subsequent Sale Period unless explicitly indicated. 

  

	 	•	 	In column (g), state the maximum number of Shares to be sold pursuant to the Option exercise. Do not aggregate with amounts authorized to be sold at a different price during the same Sale Period. 

 

	 	•	 	In column (h), write a dollar price which is the minimum price per Share (the “Limit Price”) at which the Shares are authorized to be sold during the Sale Period. All limit orders will be treated as
“limit not held” orders. Note: Option exercises and sales must be at a Limit Price, not at a “Market” price. 

  

	 	•	 	In the grid labeled “No Sale” Periods, list the time period(s), if any, during which no sales may be made, notwithstanding their inclusion in this Trade Schedule A. These periods are independent of any
suspension that may occur pursuant to this Plan. 

 This Trade Schedule A is an integral part of this Plan entered into by the Seller with
MSSB and is subject to the terms and conditions set forth therein. 

  
 Page 10 

 Trade Schedule B – Sale of Clean Stock/Control Stock/Restricted Stock Awards or Units or

 Employee Stock Purchase Plan Stock. 

Instructions: May not be applicable for some plans. For use by any seller who wishes to sell these types of shares. When applicable, to be completed by
MSSB and reviewed by the Seller.  
 Name of Seller: Caledonia Investments
PLC                Name of Issuer: Bristow Group Inc. 
 I
acknowledge that in the event the number of Shares in column (e) cannot be sold for any reason, including the occurrence of a suspension pursuant to this Plan, the term of this Plan will not be affected and will end on the originally scheduled
Plan End Date. I represent that the information below is accurate. 
 MSSB MAY NOT ACCEPT A PLAN THAT COMMENCES SALES WITHIN 14 CALENDAR
DAYS OF 
 ADOPTION DATE 

*** INFORMATION ON GRID MUST BE TYPED *** 
  

													
	 (a) Type
 (Clean
(CLN),
 Control (CTRL),
Restricted (RST),
Restricted Stock
Awards (RSA) or Units
(RSU)
or Employee
Stock Purchase Plan
shares (ESPP) )
	  	
(b) Grant ID
(If applicable)
	  	 (c) Date

Shares
 Acquired /

Vest Date
(If applicable)
	  	  
  
  

 
 (d) Sale Period(s)
	  	 (e) Authorized
Number of Owned
Shares to
be Sold
	  	 (f) Limit Price
(“Market” if
a
Market Order)

	  	  	  	 Start Date
	  	 End Date
	  	  
	 CLN
	  		  		  	The Selling Start Date	  	8/10/18	  	X	  	X
	  	  	  	The Selling Start Date	  	8/10/18	  	X	  	X
	  	  	  	The Selling Start Date	  	8/10/18	  	X	  	X
	  	  	  	The Selling Start Date	  	8/10/18	  	X	  	X
	  	  	  	The Selling Start Date	  	8/10/18	  	X	  	X
	  	  	  	The Selling Start Date	  	8/10/18	  	X	  	X

 *PLAN SALES ON ANY ONE DAY SHALL NOT EXCEED 30% OF THE TRADING VOLUME OF BRS SHARES ON SUCH DAY AS
REASONABLY ESTIMATED BY MSSB. 
  

			
	 “No Sale” Periods (if
any)

	 Start Date
	 	 End Date

		 	
		 	

 The maximum number of Shares to be sold under this Trade Schedule B is 1,835,000. 

  
 Page 11 

 Instructions for Trade Schedule B: 

 

	 	•	 	Shares should be listed in chronological order of proposed sales. 

  

	 	•	 	In column (a), indicate the type of stock to be sold. 

  

	 	•	 	In column (b), for Restricted Stock Awards/units or ESPP Shares, please state the Grant ID, if applicable. 

  

	 	•	 	In column (c), state the date the Shares to be sold were acquired or vested. If the Shares were acquired/vested in more than one lot, state the acquisition/vest date for each lot. If performance based Restricted Stock
Awards or Units and vest date is unknown at this time, indicate “TBD” in the grid above. 

  

	 	•	 	In column (d), state the first and last date on which the Shares are authorized to be sold during the designated Sale Period (Share sales may occur on or between these dates). If, during any Sale Period the stated price
is not reached for some or all of these Shares, they will not be carried over into any subsequent Sale Period, unless explicitly indicated. 

  

	 	•	 	In column (e), state the maximum number of Shares authorized to be sold at the price during the designated Sale Period. Do not aggregate with amounts authorized to be sold at a lower price during the same designated
Sale Period. 

  

	 	•	 	In column (f), write either: (i) a dollar price, which is the minimum price (the “Limit” Price) at which Shares are authorized to be sold, or (ii) the word “market” if Shares are to be sold
at the then-prevailing market price per Share during the Sale Period. All market orders will be treated as “market not held” orders. All limit orders will be treated as “limit not held” orders. 

 

	 	•	 	In the grid labeled “No Sale” Periods, list the period(s), if any, during which no sales may be made pursuant to this Trade Schedule B, stated Sale Periods, notwithstanding. These periods are
independent of any suspension that may occur pursuant to this Plan. 

 This Trade Schedule B is an integral part of this Plan entered into
by the Seller with MSSB and is subject to the terms and conditions set forth therein. 

  
 Page 12 

 PART III 

Sales Plan Disclosures and Representations 

Instructions: The Seller must review and understand these disclosures and representations. The Seller is required to sign the last page of this Part
III. 
 A. General Representations. 
 I
understand that this Plan is intended to conform with certain provisions of SEC Rule 10b5-1 of the Securities and Exchange Commission (the “Rules”). In summary, under the Rules, a person executing pre-planned transactions pursuant
to a Rule 10b5-1 plan established in good faith at a time when that person was unaware of material nonpublic information has an affirmative defense against allegations of insider trading. 

 

	 	1.	I hereby represent to MSSB that, as of the date of my signature below: 

  

	 	a.	I am not in possession, and am not aware, of any material nonpublic information about the securities which are the subject of this Plan or the Issuer of such securities; 

 

	 	b.	I am entering into this Plan in good faith and not as part of a plan or scheme to evade any law, including, without limitation, the federal securities laws or any law governing insider trading; 

 

	 	c.	I understand that the protections of the Rules may not apply if I alter this Plan or deviate from the instructions in any way, other than in accordance with the modification provisions of this Plan and applicable law;

  

	 	d.	I own the securities which are the subject of this Plan free and clear and I acknowledge and confirm that: 

  

	 	(i)	Neither I, nor the securities subject to this Plan are subject to any pledges, liens, security interests or other impediments to transfer (except for those which I have entered into with MSSB or limitations imposed by
Rule 144, if applicable), nor is there any contractual restriction or litigation, arbitration or other proceeding pending, or to my knowledge threatened, that would prevent or interfere with the exercise of options (“Options”) to
purchase shares (“Shares”) of the Issuer or sale of Shares under this Plan; and 

  

	 	(ii)	The execution and delivery of this Plan by me and the transactions contemplated by this Plan will not contravene applicable law or any agreement or other instrument binding on me or any of my affiliates or any judgment,
order or decree of any governmental body, agency or court having jurisdiction over me or my affiliates. 

  

	 	e.	While this Plan is in effect, I will not enter into any corresponding or hedging transaction or position with respect to the securities which are the subject of this Plan (including, without limitation, with respect to
any securities convertible or exchangeable into common stock of the Issuer) and, unless this Plan is modified or terminated in accordance with the terms hereof, I agree not to alter or deviate from the terms of this Plan; 

 

	 	f.	I agree not to, directly or indirectly, communicate any information relating to the Shares or the Issuer to any employee of MSSB or its affiliates who is involved, directly or indirectly, in executing this Plan at any
time while this Plan is in effect or attempt to exercise any influence over how, when or whether to effect any sales of Shares pursuant to this Plan; 

  

	 	g.	I represent that this Plan conforms with the trading policies of the Issuer, and I acknowledge and confirm that I have provided MSSB with an Issuer Representation letter dated as of the date of this Plan signed by an
authorized representative of the Issuer substantially in the form of Part IV – Exhibit A to this Plan; 

  
 Page 13 

	 	h.	I agree to notify MSSB in writing to the individuals set forth in Part I – Account and Plan Information as soon as practicable if I become aware of: 

 

	 	(i)	any restriction that would prohibit any sale pursuant to this Plan (other than any such restriction relating to my possession or alleged possession of material nonpublic information about the Issuer or its securities).
Such notice will indicate the anticipated duration of the restriction, but will not include any other information about the nature of the restriction or its applicability to me and will not in any way communicate any material nonpublic information
about the Issuer or its securities to MSSB; 

  

	 	(ii)	any change in the Issuer’s insider trading policies; 

  

	 	(iii)	any change in the Issuer’s policies with regard to the timing or method of exercising options covered by this Plan; 

  

	 	(iv)	any change that would cause the sales hereunder not to meet all applicable requirements of Rule 144, if applicable; and 

  

	 	(v)	any stock split, stock dividend or other like distributions affecting the Shares (“Recapitalization”). 

  

	 	i.	I acknowledge that MSSB is not acting as my fiduciary but is acting in a brokerage capacity in connection with the adoption and implementation of this Plan; 

 

	 	j.	I agree that until this Plan has been terminated in accordance with its terms, I will not, without providing prior written notice to MSSB: 

 

	 	(i)	enter into a binding contract with respect to the purchase or sale of any securities of the Issuer with another broker, dealer or financial institution (each, a “Financial Institution”);

  

	 	(ii)	instruct another Financial Institution to purchase or sell any securities of the Issuer; or 

  

	 	(iii)	adopt a plan for trading with respect to any securities of the Issuer other than this Plan. 

  

	 	k.	If I am a director or executive officer of the Issuer, then I am not subject to any current pension fund blackout period applicable to such Issuer, and I have not received written notice of the imposition of, nor am I
aware of, the actual or approximate beginning or ending dates of any such blackout period and I further acknowledge and agree that I may not modify or otherwise alter this Plan in such circumstances; 

 

	 	l.	I represent that I am not entering into this Plan on behalf of, or with the assets of, an individual retirement account or individual retirement annuity, or any employee retirement or employee benefit plan (such as, for
example, a Keogh or “HR-10” plan). [Explanatory Note: A plan involving the sale of stock acquired through the exercise of employee stock options would not be “on behalf of, or with the assets of’ any of the types of plans
referred to in this paragraph.] 

  

	 	m.	I represent that my account is not an “employee benefit plan” within the meaning of Section 3(3) of the Employee Retirement Income Security Act of 1974, as amended, or a “plan” as defined under
Section 4975(e) of the Internal Revenue Code of 1986, as amended, or an entity whose underlying assets include the assets of any such plan by reason of such a plan’s investment in such entity. 

B. Section 16 Representations (note: may not be applicable for some plans). 

 

	 	1.	I understand that it is my responsibility to comply with all applicable laws (including, without limitation, Section 16 of the Exchange Act and the rules and regulations promulgated thereunder, if applicable) and
policies of the Issuer of the securities with respect to the transactions contemplated by this Plan (“Covered Transactions”) and agree to comply with all such laws and policies; 

 

	 	2.	If I have specified that I am subject to the requirements of Section 16 of the Exchange Act, I agree to complete, execute and deliver to MSSB a Section 16 Authorization Letter substantially in the form of
Part IV – Exhibit C to this Plan; 

  
 Page 14 

	 	3.	I understand that federal securities laws may require me to disgorge all profits earned in connection with any purchase and sale of securities that occurs within six months of each other if I own 10% or more of any
class of the Issuer’s equity securities, or if I am an officer or director of the Issuer (i.e., “short-swing profits”). I further understand that it is my own responsibility to ensure compliance with such short-swing profit
rules, and I will seek my own counsel with respect to ensuring compliance with such rules; 

  

	 	4.	I understand that there are securities laws and rules that require certain persons to timely file reports with the Securities and Exchange Commission (the “SEC”) as to the shareholder’s purchases
and sales of the Issuer’s securities (including, without limitation, Section 13 and Section 16 of the Exchange Act). I understand that it is my responsibility to ensure compliance with such rules in a timely manner to the extent
applicable, and I will seek my own counsel with respect to whether and when such reports might need to be filed. MSSB will not be required to: (i) make any of these filings on my behalf, (ii) review any Exchange Act filing made by me, or
(iii) determine whether any Exchange Act filing by me has been made on a timely basis. MSSB will not be liable to me for any misstatement, omission or defect in any of these filings; and 

 

	 	5.	I understand that the laws governing insider trading are fact-specific and that MSSB does not and cannot guarantee that any transaction that is executed pursuant to this Plan will be deemed covered by the protections of
the Rules. 

 C. Sales of Restricted Stock or Control Stock Pursuant to SEC Rule 144 (note: may not be applicable for some plans). 

  

	 	1.	I understand that this Plan is applicable only as to securities that are freely-tradable and that are not subject to any restrictions against purchase or sale. If I am considered an “Affiliate” within the
meaning of Rule 144, then I understand that the provisions of that rule may limit the number of Shares I can sell at any given time. In the event there is a conflict between the quantity of securities that I have directed to be sold and any lesser
amount of Shares that are permitted to be sold pursuant to Rule 144 or other securities laws or rules, I hereby direct that the maximum limits established by such other laws or rules shall govern. In no event will MSSB effect any sale if such sale
would exceed the then-applicable limitation under Rule 144 assuming MSSB’s sales under this Plan are the only sales subject to that limitation. 

  

	 	2.	I agree not to take nor to cause any person or entity with which I would be required to aggregate sales of stock pursuant to Rule 144 to take, any action that would cause the sales hereunder not to meet all applicable
requirements of Rule 144, including volume limitations. 

  

	 	3.	I instruct MSSB to conduct all sales pursuant to this Plan in accordance with the manner of sale under Rule 144(f) and current public information requirements of Rule 144(c). 

 

	 	4.	I agree to timely provide completed and signed Rule 144 paperwork to MSSB (including, without limitation, a Seller Representation letter dated as of the date of this Plan substantially in the form of Part IV –
Exhibit B to this Plan prior to the Adoption Date). I acknowledge that MSSB requires this paperwork to facilitate Rule 144 trades for my account. Consistent with Rule 144 filing requirements, MSSB hereby agrees to submit my completed Form 144
– Notice of Proposed Sale to the Securities and Exchange Commission . In order for MSSB to complete this paperwork, I authorize MSSB to maintain my pre-signed Forms 144 in safekeeping and to complete these forms as necessary before submitting
them to the SEC. I further agree to release, hold harmless and discharge MSSB and their affiliates, agents, officers, successors and insurers from any and all claims, demands, losses, liabilities, damages and other expenses which may be sustained at
any time relating to its facilitating transactions and completing necessary paperwork on my behalf under Rule 144. 

 D. Implementation,
Modification, Suspension and Termination. 
  

	 	1.	Implementation of Plan. 

  

	 	a.	MSSB will sell the Shares subject to this Plan in accordance with the terms of this Plan for my account in accordance with the principles of best execution provided that MSSB may execute orders on a “not held”
basis. MSSB considers several factors, including price, the available liquidity pool, execution speed, transaction costs, service and opportunities for price improvement in determining where to route customer orders for execution. A “not
held” or “working order” permits MSSB to use reasonable brokerage judgment, exercising price and time discretion, as to when to execute the order. However, MSSB will not sell any Shares subject to this Plan at a price less than the
Limit Price, if applicable. 

  
 Page 15 

	 	b.	MSSB may sell the Shares subject to this Plan on any national securities exchange, in the over-the-counter market, on an automated trading system or otherwise. I agree that if MSSB or its affiliates is a market maker or
dealer in such Shares at the time that any sale is to be made under this Plan, MSSB or its affiliates may, at its sole discretion, purchase such Shares in its capacity as market maker or dealer. 

 

	 	c.	I agree to deliver the Shares subject to this Plan to the extent I currently own such Shares into an account at MSSB in my name and for my benefit prior to the Selling Start Date. I understand that this Plan shall not
be effective until I establish a valid account at MSSB to hold the Shares. 

  

	 	2.	Modification of Plan. 

  

	 	a.	I may not modify this Plan unless: 

  

	 	(i)	such modification is accepted in writing by MSSB; 

  

	 	(ii)	I provide MSSB with: 

  

	 	(a)	an Issuer Representation Letter substantially in the form of Part IV – Exhibit A to this Plan; 

  

	 	(b)	a Seller Representation Letter substantially in the form of Part IV – Exhibit B to this Plan; 

  

	 	(c)	a modification letter and new trade schedule(s) in which I represent that, among other things, on the date of such modification that I am not aware of any material, non-public information regarding the Issuer or any of
its securities (including the Shares), that the modification is being made in good faith and not as part of a scheme to evade the Rules, and that my representations and warranties contained in this Plan are true at and as of the date of such letter
as if made at and as of such date; and 

  

	 	(d)	such modification occurs only outside of any “blackout periods” set forth in the Issuer’s insider trading policy and procedures. 

 

	 	b.	I further understand that MSSB requires a 14 day period from the adoption of such modification to the date when trading may resume following such modification. The Issuer may impose additional requirements as a
condition of allowing me to modify this Plan, including, but not limited to, an additional period of time which must elapse before trading may resume following such modification. I agree to comply with any such additional requirements imposed by
Issuer and to advise MSSB of such requirements. I further agree that any such modification of this Plan shall be undertaken at my own risk without liability or consequence to MSSB. 

 

	 	3.	Suspension of Plan. 

  

	 	a.	I understand that trading under this Plan may be suspended if MSSB has received written notice from the Issuer or from me of a legal, regulatory or contractual restriction applicable to the Issuer or to me. Upon receipt
of such written notice, I expressly authorize MSSB to suspend trading as soon as practicable and trading shall not resume until MSSB has received written notice of the lifting of such suspension or the resolution of the underlying restriction. If
the events giving rise to a suspension of trading cannot be resolved (as determined by MSSB in its sole discretion), I understand and acknowledge that MSSB reserves the right, in its sole discretion, to terminate this Plan in accordance with the
provisions contained herein. In the event of a suspension, MSSB will resume effecting trades in accordance with this Plan as soon as MSSB determines that it is reasonably practical to do so. 

 

	 	b.	Upon the resumption of trading following a suspension, any trades having a Sales Period End Date scheduled to have occurred during such suspension period shall be deemed to have expired as of that scheduled Sales Period
End Date as defined in Trade Schedule A or B, as applicable. Any trades having a Sales Period Start Date scheduled to have occurred during the period of suspension shall be placed as soon as practicable for the balance of time
remaining until the Sales Period End Date applicable to such trade. All other trades shall be placed as originally indicated in this Plan. 

  
 Page 16 

	 	4.	Termination of Plan. 

  

	 	a.	I understand that this Plan will terminate at market close on the Plan End Date or, if earlier, upon the completed sale of the maximum Shares subject to this Plan. In addition, this Plan shall terminate, regardless of
whether the maximum Shares have been sold, upon any of the following events: 

  

	 	(i)	MSSB receives written notice of my death; 

  

	 	(ii)	MSSB receives written notice of the commencement or impending commencement of any proceedings in respect of or triggered by my bankruptcy or insolvency; 

 

	 	(iii)	MSSB receives written notice of a valid instruction to transfer all or substantially all of the assets within my securities account at MSSB to another broker-dealer; 

 

	 	(iv)	MSSB receives two days’ written notice from me terminating this Plan (which may be given for any reason); 

  

	 	(v)	I receive written notice from MSSB terminating this Plan (which may be given for any reason); and 

  

	 	(vi)	If I fail to comply in any material respect with any applicable law and/or any obligation under this Plan. 

  

	 	(vii)	Upon my or the Issuer’s demonstrating to MSSB that any of the following contingencies have occurred: 

  

	 	(a)	A public announcement has been made of a tender offer involving the Issuer’s securities; 

  

	 	(b)	A definitive agreement has been announced relating to a merger, reorganization, consolidation or similar transaction in which the securities covered by this Plan would be subject to a lock-up provision;

  

	 	(c)	A sale has been made of all or substantially all of the assets of the Issuer on a consolidated basis to an unrelated person or entity, or if a transaction affecting the Issuer occurs in which the owners of the
Issuer’s outstanding voting power prior to the transaction do not own at least a majority of the outstanding voting power of the successor entity immediately upon completion of the transaction; 

 

	 	(d)	A dissolution or liquidation of the Issuer takes place or there is a commencement or impending commencement of any proceedings in respect of or triggered by the Issuer’s bankruptcy or insolvency; or

  

	 	(e)	That this Plan or its attendant transactions may violate existing, new or revised federal or state laws or regulations, or may cause a breach of a contract or agreement to which the Issuer is a party or by which the
Issuer is bound. 

  

	 	b.	In no event shall MSSB be deemed to have breached or failed to comply with this Plan if MSSB does not receive written notice from me or the Issuer of the above contingencies prior to the placement of a scheduled order
under this Plan. 

 E. Indemnification; Limitation of Liability.  

I understand that the purpose of this Plan is to provide me with an affirmative defense against charges of insider trading and that MSSB can make no
representation or guarantee that any transaction entered according to this Plan will not subsequently be found to violate federal or state laws or rules against trading by insiders or trading on the basis of material nonpublic information or other
laws or rules governing securities transactions. Therefore, in consideration of MSSB’s acceptance of these instructions, I hereby agree to indemnify and hold harmless MSSB and its directors, officers, employees and affiliates (including,
without limitation, Morgan Stanley & Co. LLC) from any claim, loss, damage, liability or expense (including, without limitation, any legal fees and expenses reasonably incurred) arising out of or attributable to this Plan (including,
without limitation, any representations or warranties I have given or will give under or in connection with this Plan) or any transaction or transactions executed pursuant to this Plan or from any deviation I might make from this Plan. This
indemnification will survive termination of this Plan. 

  
 Page 17 

 Notwithstanding any other provision hereof, MSSB shall not be liable to me for (i) any special, indirect,
punitive, exemplary or consequential damages, or incidental losses or damages of any kind, even if advised of the possibility of such losses or damages or if such losses or damages could have been reasonably foreseen, or (ii) any failure to
perform or to cease performance or any delay in performance that results from a cause or circumstance that is beyond MSSB’s reasonable control, including but not limited to, failure of electronic or mechanical equipment, strikes, failure of
common carrier or utility systems, outbreak or escalation of hostilities or other crisis or calamity, severe weather, market disruptions, material disruptions in securities settlement, payment or clearance services or other causes commonly known as
“acts of God”. 
 F. Notice. 
 All notices and
other communications provided for herein shall be in writing and shall be delivered by hand or overnight courier service, mailed by certified or registered mail or sent by telecopier or electronic mail and made to the applicable persons indicated in
Part I – Account and Plan Information. The parties acknowledge and agree that the distribution of material through an electronic medium is not necessarily secure and that there are confidentiality and other risks associated with such
distribution. 
 G. Miscellaneous. 
  

	 	1.	Additional Documents. I agree to complete, execute and deliver to MSSB any additional forms or other paperwork pursuant to this Plan at such times and in such form as MSSB may reasonably request.

  

	 	2.	My Obligation to Consult Legal Advisors. I agree that I will not enter into, modify, suspend or terminate this Plan except upon consultation with my own legal advisors. 

 

	 	3.	Inconsistent Provisions. If any provision of this Plan is or becomes inconsistent with any applicable present or future law, rule or regulation, that provision will be deemed rescinded to the extent required in
order to comply with the relevant law, rule or regulation. All other provisions of this Plan will continue and remain in full force and effect. 

  

	 	4.	Market Disruptions and Other Unusual Situations. I understand that MSSB may not be able to effectuate a sale due to a market disruption or a legal, regulatory or contractual restriction to which it, its
affiliates, me or my affiliates may be subject (as determined by MSSB in its sole discretion). If any transaction cannot be executed due to a market disruption, a legal, regulatory, or contractual restriction applicable to MSSB, or any other event,
MSSB agrees to effectuate such sale as promptly as practical after the cessation or termination of such market disruption, applicable restriction or other event; provided that such date does not exceed the Sales Period End Date for that order or the
Plan End Date, or falls within a No Sales Period as defined in Trade Schedule A and/or B of this Plan. 

  

	 	5.	Non-Market Days and Trading Restrictions. If I have given instructions that require an order to be entered on a particular date, and the date that I have selected for a transaction falls on a day when the
applicable primary market for the security is closed, then I direct that the transaction occur on the next regular business day on which such market is open following the original date indicated; provided that such date does not exceed the Sales
Period End Date for that order or the Plan End Date or falls within a No Sales Period as defined in Trade Schedule A and/or B of this Plan. 

  

	 	6.	State Insider Trading Laws. I understand that some states may have their own laws that relate to insider trading. I understand that MSSB makes no representation to me with respect to whether this Plan conforms to
the laws of any particular state, and that I will seek the advice of my own counsel with respect to matters of state law. 

  

	 	7.	Prices. All references in this Plan to per share prices will be before deducting any commission equivalent, mark-up or differential and other expenses of sale. 

 

	 	8.	Other Shares. I may instruct MSSB to sell securities of the Issuer other than pursuant to this Plan. The parties hereto agree that any such sale transaction will not be deemed to modify this Plan unless in
connection with such transaction this Plan is modified pursuant to the process set forth in subsection D.2 above. 

  

	 	9.	Adjustments to Share and Dollar Amounts. The exercise and sale prices, and number of Options to be exercised and Share to be sold, will be adjusted following such time as I or the Issuer notifies MSSB promptly of
a Recapitalization, which shall be made by providing a new schedule reflecting the adjustment in Shares and prices after the Recapitalization. 

  
 Page 18 

	 	10.	Effect of Instructions on Other Agreements with MSSB. Subject to “Entire Agreement; Subsequent Plans” subsection below, nothing in this Plan changes any other terms or agreements that are already
applicable to my account or accounts, or that otherwise exist between MSSB and me. 

  

	 	11.	Entire Agreement; Subsequent Plans. This Plan constitutes the entire agreement between the parties with respect to this Plan and supersedes any prior agreements or understandings with respect to this Plan. I
understand that if I enter into a subsequent 10b5-1 trading plan, that plan will not amend, suspend or terminate this Plan unless explicitly agreed to by MSSB in writing. 

 

	 	12.	Assignment. My rights and obligations under this Plan may not be assigned or delegated without the written permission of MSSB. MSSB may assign or delegate any or all of its rights or obligations under this Plan
to a company affiliated with, or a successor to, MSSB or to any assignee to which MSSB determines to assign all or part of its business relating to sales plans of this kind. Any such assignment will not affect the status, or be deemed to be an
amendment, of this Plan, the purpose of which is to provide me with an affirmative defense against charges of insider trading. 

  

	 	13.	Choice of Law Regarding Interpretation of Instructions. This Plan shall be construed in accordance with the internal laws of the State of New York. 

 

	 	14.	Enforceability in the Event of Bankruptcy. The parties acknowledge and agree that this Plan is a “securities contract” as defined in Section 741(7) of Title 11 of the United States Code
(“Bankruptcy Code”) and shall be entitled to all of the protections afforded to such contracts under the Bankruptcy Code. 

  

	 	15.	Headings. Headings used in this Plan are provided for convenience only and shall not be used to construe meaning or intent. 

  

	 	16.	Counterparts. This Plan may be signed in any number of counterparts, each of which shall be deemed an original, with the same effect as if the signatures thereto and hereto were placed upon the same instrument.

 By signing this Plan I agree that I have read and understood all of the disclosures and representations outlined in this Plan and
applicable Trade Schedules. 
  

									
	Seller	 		 	Morgan Stanley Smith Barney LLC
					
	By:	 	/s/ Graeme Denison	 		 	By:	 	/s/ Jason Nigro
	Name: Caledonia Investments PLC	 		 	Name: Jason Nigro
	Title: Company Secretary	 		 	Title: Executive Director
			
	Adoption Date: February 20, 2017	 		 	Date: February 21, 2017

  
 Page 19 

 PART IV 

Exhibit A 
 Instructions: To be
reviewed and executed by an authorized representative of the Issuer. 
 Issuer Representation Letter 

Reference is made to that certain Sales Plan dated February 20, 2017 (the “Plan”) between Caledonia Investments PLC
(“Seller”) and Morgan Stanley Smith Barney LLC (“MSSB”) relating to the sale of common shares (the “Shares”) of Bristow Group Inc. (the “Issuer”). 

As an authorized representative of the Issuer, I hereby represent and covenant on the Issuer’s behalf that: 

 

	 	1.	The Seller’s affiliate status at the Issuer is a (check the applicable boxes): 

  

	 	☒	144 affiliate of the Issuer 

  

	 	☐	Section 16 insider 

  

	 	☐	Subject to the Issuer’s insider trading windows 

  

	 	☐	Not Applicable 

 2. The sales to be made by MSSB for the account of Seller pursuant to the Plan
will not violate the Issuer’s insider trading policies and, to the best of the Issuer’s knowledge, there are no legal, contractual or regulatory restrictions applicable to Seller or Seller’s affiliates as of the date of this
representation that would prohibit Seller from entering into the Plan or prohibit any sale pursuant to the Plan. 
 3. If, at any time
between the Adoption Date and the Plan End Date (each as defined in the Plan), (i) the Issuer becomes aware of a legal, contractual or regulatory restriction that is applicable to Seller or Seller’s affiliates or a stock offering requiring
an affiliate lock-up, which would prohibit any sale pursuant to the Plan (other than any such restriction relating to Seller’s possession or alleged possession of material nonpublic information about the Issuer or its securities),
(ii) there is a change in the Issuer’s insider trading policies, so that the sales to be made by MSSB for the account of the Seller pursuant to the Plan would violate these policies or (iii) where the Plan covers Shares that Seller
has the right to acquire under outstanding stock options, there is a change in the Issuer’s policies with regard to the timing or method of exercising such options which could interfere with the manner or timing of the sales to be made pursuant
to this Plan, the Issuer agrees to give MSSB’s PDP Trading Desk notice of such restriction in writing as soon as practicable to the individuals identified in Part I – Account and Plan Information of the Plan. Such notice shall be
made to and shall indicate the anticipated duration of the restriction, but shall not include any other information about the nature of the restriction or its applicability to Seller or otherwise communicate any material nonpublic information about
the Issuer or its securities to MSSB. 
 4. If the Plan covers Shares that Seller has the right to acquire under outstanding stock options,
the Issuer acknowledges that Seller has authorized MSSB to serve as Seller’s agent and attorney-in-fact to exercise such stock options to purchase the Shares from time to time pursuant to the Plan. The Issuer agrees to accept, acknowledge and
effect the exercise of such options by MSSB and the delivery of the underlying Shares to MSSB (free of any legend or statement restricting its transferability to a buyer) upon receipt of a completed Trade Schedule A – Notice and
Authorization of Exercise of Stock Options of Sale included in Part II of the Plan. 
 Dated:
February 20        , 2017 
  

					
		
	By:	 	/s/ E. Chipman Earle
		 	Name:	 	E. Chipman Earle
		 	Title:	 	 Senior Vice President & Chief
 Legal and
Support Officer

  
 Page 20 

 Exhibit B 
  

			
	

	  	 Caledonia Investments plc
 2nd Floor
Stratton House
 5 Stratton Street
 London W1J 8LA

United Kingdom
  

tel    +44 20 7802 8080

fax   +44 20 7802 8090
 enquiries@caledonia.com

www.caledonia.com

 Seller
Representation Letter 
 Morgan Stanley Smith Barney LLC 

1 New York Plaza, 38th Floor 

New York, NY 10004 
 Attention: 10b5-1 Preset Diversification
Program Department 
 Re: Sale of 1,835,000         Shares (the “Stock”) of
Bristow Group Inc. (the “Issuer”) Pursuant to Rule 144 
 Dear Sirs/Madams: 

The undersigned, Caledonia Investments PLC, proposes to sell the above-referenced Stock of the Issuer through Morgan Stanley Smith Barney LLC
(“MSSB”) in accordance with the requirements of Rule 144 under the Securities Act of 1933, as amended (the “Act”). The undersigned is an “affiliate” of the Issuer as that term is defined in Rule 144(a)(1).
Accordingly, the undersigned delivers to you herewith a signed copy of a Notice of Proposed Sale of Securities Pursuant to Rule 144 (Form 144) relating to such sale, and confirms to you that the statements made therein are true and complete and
represents to and agrees with you that: 
  

	 	1.	The undersigned does not know or have any reason to believe that the Issuer has not complied with the reporting requirements contained in Rule 144(c)(1); 

 

	 	2.	The Issuer is not, and has not been, a shell issuer as that term is defined in Rule 144(i)(1); 

  

	 	3.	With respect to any shares of the Stock that are restricted securities, as that term is defined in Rule 144(a)(3), a minimum of 6 months has elapsed since the date of acquisition of the Stock from the Issuer or an
affiliate of the Issuer, and payment of the full purchase price, by the undersigned; 

  

	 	4.	At the time of any sale of the Stock for the account of the undersigned, the number of shares of the Issuer’s common stock sold by the undersigned or for the undersigned’s account and by or for the account of
any person whose sales are required by paragraph (a)(2) and paragraph (e)(3) of Rule 144 to be aggregated with sales by or for the undersigned (other than shares sold pursuant to a registration statement under the Act, an exemption provided by
Regulation A under the Act, or an exemption contained in Section 4 of the Act) will not exceed the amounts permitted by Rule 144(e); 

  

	 	5.	The undersigned has not solicited or arranged for the solicitation of, and will not solicit or arrange for the solicitation of, orders to buy the Stock in anticipation of or in connection with such proposed sale, and
such sale shall be made in accordance with Rule 144(f); 

  

	 	6.	The undersigned has not made, and will not make, any payment in connection with the offering or sale of the Stock to any person other than the usual and customary compensation to MSSB; 

  
 Page 21 

	 	7.	No share of the Stock is subject to any agreement granting any pledge, lien, mortgage, hypothecation, security interest, charge, option or encumbrance, other than those which may have been entered into between the
undersigned and MSSB; 

  

	 	8.	The undersigned authorizes MSSB to complete the Form 144 (“Form 144”) and this Seller’s Representation Letter (this “Letter”), including, but not limited to, completing the number
of shares of Stock to be sold and any dates, as may be necessary to reflect my instructions, which may be written or oral, and the facts of the transaction as effected, and to use Form 144 and this Letter as appropriate to comply with Rule 144 and
to effect settlement of any sale made in conjunction herewith; and 

  

	 	9.	The undersigned agrees to notify MSSB promptly if there are any changes to the facts or representations set forth in this Letter or in the accompanying Form 144 (if applicable) and hereby authorizes MSSB, if MSSB deems
it necessary, to contact the Issuer, its counsel, its transfer agent, and their agents and representatives concerning this transaction. MSSB and its agents and representatives, the Issuer, its transfer agent and their agents and representatives may
rely on the accuracy of the information contained in this Letter. 

 Sincerely yours, 

/s/ Graeme Denison, Company Secretary 
 For and on behalf of
Caledonia Investments plc 
 February 20, 2017 

  
 Page 22 

 
					
	
OMB APPROVAL

	OMB Number:	 	3235-0101
	Expires:	 	May 31, 2017
	Estimated average burden
	hours per response	 	1.00

  

 

			
	 UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549
  

FORM 144
  

NOTICE OF PROPOSED SALE OF SECURITIES

PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933

 
	  	SEC USE ONLY
	  	 DOCUMENT SEQUENCE NO.

 

	  	 CUSIP NUMBER

 

	  	WORK LOCATION
	  	 

			
	

	ATTENTION:	Transmit for filing 3 copies of this form concurrently with either placing an order with a broker to execute sale or executing a sale directly with a market maker. 

 

							
	 1(a) NAME OF ISSUER (Please type or print)

Bristow Group Inc.
	 	 (b) IRS IDENT. NO.

72-0679819
	 	
(c) S.E.C. FILE NO.

001-31617

													
	1(d) ADDRESS OF ISSUER	  	STREET	  	CITY                	 	STATE        	    	ZIP CODE    	 	(e) TELEPHONE NO.
	 	  		  		 		    		 	AREA CODE 	  	NUMBER
	2103 City West Blvd. 4th Floor	  		  	Houston	 	Texas	    	77042	 	713	  	267-7600

																			
	
2(a) NAME OF PERSON FOR WHOSE ACCOUNT
        THE SECURITIES ARE TO BE SOLD

10b5-1 Sales Plan for Caledonia Investments Plc
	    	 	 	 (b) RELATIONSHIP TO 
       ISSUER
 Affiliate
	 	 (c) ADDRESS    STREET

 
 Stratton House 5, Stratton Street
	    	 CITY

 
 London,
	 	 STATE

 
 UK
	    	
ZIP CODE

 INSTRUCTION: The person filing this notice should contact the issuer to obtain the I.R.S. Identification
Number and the S.E.C. File Number. 
  

																																							
	3(a)                	  	(b)	  	 	  	SEC USE ONLY	  	(c)	  	(d)	 	(e)	  	(f)	  	(g)
	
Title of the

Class of
 Securities

To Be Sold
	  	 Name and Address of Each Broker
Through Whom
 the Securities are to be Offered or Each Market

Maker who is Acquiring the Securities

 
	  	 Broker-Dealer

File Number
	  	 Number of Shares

or Other Units
 To Be
Sold
 (See instr. 3(c))
	  	 Aggregate

Market Value
  

(See instr. 3(d))
	 	 Number of Shares

or Other Units

Outstanding
 (See instr.
3(e))
	  	 Approximate

Date of Sale

(See instr. 3(f))

(MO. DAY YR.)
	  	
Name of Each

Securities
 Exchange

(See instr. 3(g))

	 	 	 	 	 	 	 	 
	COMMON	  	 Morgan Stanley Smith Barney LLC

1 New York Plaza, 38th Floor

New York, NY 10004
 Attn: Natalie
Siriban-Lee
	  	 	  	 	  	 	 	 	  	 	  	NYSE

 

 

					
	INSTRUCTIONS:
	 1.
	 	(a)	 	Name of issuer
		 	(b)	 	Issuer’s I.R.S. Identification Number
		 	(c)	 	Issuer’s S.E.C. file number, if any
		 	 (d)
 (e)
	 	 Issuer’s address, including zip code

Issuer’s telephone number, including area code

			
	 2.
	 	(a)	 	Name of person for whose account the securities are to be sold
		 	(b)	 	Such person’s relationship to the issuer (e.g., officer, director, 10% stockholder or member of immediate family of any of the foregoing)
		 	(c)	 	Such person’s address, including zip code

					
			
	3.	 	(a)	 	Title of the class of securities to be sold
		 	(b)	 	Name and address of each broker through whom the securities are intended to be sold
		 	(c)	 	Number of shares or other units to be sold (if debt securities, give the aggregate face amount)
		 	(d)	 	Aggregate market value of the securities to be sold as of a specified date within 10 days prior to the filing of this notice
		 	(e)	 	 Number of shares or other units of the class outstanding, or if debt securities the face amount thereof outstanding, as shown by
the most recent report or statement published by the issuer
 Approximate date on which the securities are to be sold

		 	(f)	 
		 	(g)	 	Name of each securities exchange, if any, on which the securities are intended to be sold

 
 

  
 Potential persons who
are to respond to the collection of information contained in this form are not 
 required to respond unless the form displays a
currently valid OMB control number. 

 TABLE I—SECURITIES TO BE SOLD 

Furnish the following information with respect to the acquisition of the securities to be sold 

and with respect to the payment of all or any part of the purchase price or other
consideration therefor: 
  

																					
	
Title of
 the Class
	  	 Date you  

Acquired  
	  	Nature of Acquisition Transaction	  	
Name of Person from Whom Acquired

(If gift, also give date donor acquired)
	  	Amount of
Securities Acquired	  	 Date of  

Payment  
	  	Nature of
Payment
	 		 	 		 		 		 	 
	 	  	 	  	 	  	 	  	 	  	 	  	 	  	 	  	 	  	 	  	 

																					
		
	INSTRUCTIONS:	  	If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted
of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

  
  

																					
	
	 TABLE II—SECURITIES SOLD DURING THE PAST 3 MONTHS

 
 Furnish the following information as to all securities of the issuer sold
during the past 3 months by the person for whose account the securities are to be sold.
  

	Name and Address of Seller	 	Title of Securities Sold	 	Date of Sale    	 	Amount of    
Securities Sold    	 	Gross Proceeds    
	 	 	 	 	 
	 	 	 	 	 	 	 	 	 

 REMARKS: 
  

			
	 INSTRUCTIONS:
 See the definition of
“person” in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be
given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
	    	 ATTENTION:
 The person for whose
account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to
be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or
the instruction given, that person makes such representation as of the plan adoption or instruction date.

		
	  
 DATE OF NOTICE
	    	  
 (SIGNATURE)

		
	  
 DATE OF PLAN ADOPTION OR GIVING OF
INSTRUCTION,
 IF RELYING ON RULE 10B5-1
	    	The notice shall be signed by the person for whose account the securities are to be sold. At least one copy of the notice shall be manually signed. Any copies not manually signed shall bear typed or printed
signatures.

 ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18
U.S.C. 1001).

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00267-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00267-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00267-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00267-of-00352.parquet"}]]